Prime-time

Trump to deliver prime-time address tonight, EV transition unravels, oil sinks to 4-year low, Spirit and Frontier Airlines eye merger, and Warner Bros. plans to reject Paramount bid...

 

Good morning.

The Fast FiveTrump to deliver prime-time address tonight, EV transition unravels, oil sinks to 4-year low, Spirit and Frontier Airlines eye merger, and Warner Bros. plans to reject Paramount bid…

📌 Elon: Tesla's Next Move Could "Affect the Future of the World"—Get ready for what could be the biggest corporate pivot in US history. Tesla insiders are preparing for a dramatic new launch (not driverless cars) but something far bigger. You're almost out of time to prepare. Our top stock idea (name + ticker) revealed here. (ad)

Calendar: (*Shutdown may affect key data. All times ET) - Full Calendar »

  • Today:
    Non watched

  • Tomorrow:
    Consumer Price Index, 8:30A Unemployment Claims, 8:30A

Your 5-minute briefing for Wednesday, Dec 17:

BEFORE THE OPEN

As of market close 12/16/2025.

Pre-Market:

US Investor % Bullish Sentiment:
↑ 44.59% for Week of DEC 11 2025

Previous week: 44.29%

Market Wrap:

  • Futures lower after S&P logs third straight loss

  • S&P -0.3%, Nasdaq -0.4%, Dow -0.2%

  • October jobs -105K; unemployment rises to 4.6%

  • November payrolls +64K, above estimates

  • Energy stocks slide as oil hits 2021 lows

  • CPI due Thursday; Fed speakers today

EARNINGS

Here’s what we’re watching this week:

Alert: Huge Tesla Shift Ahead?

Tesla could be on the verge of its biggest change ever. Insiders are warning of a coming "critical inflection point" that could have ripple effects across the entire stock market.

Do NOT buy or sell Tesla stock until you see this.

- a message from Altimetry -

HEADLINES

President Trump said he would deliver a prime-time address to the nation on Wednesday night, an opportunity to tout his agenda to voters with polls showing the public souring on his approach to the economy.

The global transition to electric vehicles is beginning to unravel the way major changeovers often do: slowly at first, then all at once.

  • Dow, S&P 500 slide after mixed-bag jobs report (more)

  • Bostic argues Fed should not cut rates at all next year (more)

  • Jobs report doesn't 'meet the test' for another Fed rate cut (more)

  • US payrolls rise after October drop, unemployment marches higher (more)

  • Oil sinks to 4-year low with market 'cartoonishly oversupplied' (more)

  • Imports to busiest US seaport tumble 11.5% in November as tariffs bite (more)

  • Kushner’s Affinity Partners exits \Warner Bros. takeover battle (more)

    • Warner Bros. plans to reject Paramount bid (more)

  • Michaels posts 40% earnings growth in epic comeback rrom tariffs (more)

  • Waymo in talks to raise billions at over $100B valuation (more)

  • Spirit and Frontier Airlines eye merger (more)

  • Trump era opens banking license for fintechs (more)

  • Activist investors are losing the Big Three (more)

  • Kraft Heinz taps former Kellogg chief as CEO to steer split (more)

DEALFLOW

M+A | Investments

  • BlackLine acquires WiseLayer

  • Strada receives investment from OWC

  • NextPoint Group receives investment from Godspeed Capital Management

  • Synergetics.ai receives strategic investment from Taisu Ventures

  • Woodchuck received an investment from Michigan Rise

  • Cofactor Genomics receives investment from Labcorp and Ascension Ventures

VC

  • Databricks, a data and AI company, raised a >$4B Series L investment, valuing it at $134B

  • BlossomHill Therapeutics, Inc., a clinical-stage biopharma company, raised $84M in Series B extension funding

  • Adaptive Security, an AI-powered social engineering prevention solutions, raised $81M in Series B funding

  • Aeovian Pharmaceuticals, a clinical-stage biopharmaceutical company, raised $55M in funding

  • Esusu, a fintech platform, raised $50M in its Series C funding, at $1.2B valuation

  • Nanit, a baby's sleep technology company, raised $50M in growth funding

  • PsiThera, a biotech company specializing in computational intelligence, raised $47.5M in Series A funding

  • Fluency, a digital advertising OS, raised $40M in Series A funding

  • Axion, an AI platform for manufacturing product quality, raised $37M in Series B funding

  • Echo Software, a leader in AI-powered secure software infrastructure, raised $35M in Series A funding

  • Thread, the parent company of Thread Bank, a wholly-owned subsidiary, raised $30.5M in funding

  • Vital Lyfe, a personal water-making technology company, raised $24M in Seed funding

  • Ember LifeSciences, a provider of cold chain technology, raised $16.5M in Series A funding

  • YSE Beauty, a skincare brand, closed a $15M Series A funding round

  • Looma, an in-store retail media platform, raised $13M in funding

  • Dux, an agentic exposure management platform, raised $9M in Seed funding

  • Verisoul, a platform for stopping fake accounts and fraud, raised $8.8M in Series A funding

  • Mobius Materials, a B2B marketplace for hardware manufacturers, raised $3M in funding

  • Curalta Foot & Ankle, a network of foot and ankle care providers, raised a new funding round

  • Culture Biosciences, a company specializing in cloud-based biomanufacturing, raised an undisclosed amount in Series C funding

CRYPTO

  • Bitcoin fatigue sets in as token heads for fourth annual loss (more)

  • Bitcoin keeps sliding, and the true believers keep buying (more)

  • FDIC proposes first US stablecoin rule to emerge from GENIUS Act (more)

BULLISH BITES

🤖  AI promised a revolution. Companies are still waiting.

💼 Five worrying employment trends buried in the latest jobs report.

💰 A pretty penny: Last US cents sell for $16.7 million.

🤯 AI’s frontmen are blowing it.

DAILY SHARES

What did you think of today's Briefing?

Login or Subscribe to participate in polls.

Have a comment or suggestion?
💌 Send us a message

*sponsored message

Disclaimer: Market Briefing© is a news publisher. All statements and expressions herein are the sole opinions of the authors or paid advertisers. The information, tools, and material presented are provided for informational purposes only, are not financial advice, and are not to be used or considered as an offer to buy or sell securities; and the publisher does not guarantee their accuracy or reliability. Please conduct your own research and consult an independent financial adviser before making any investments. Neither the publisher nor any of its affiliates accepts any liability whatsoever for any direct or consequential loss howsoever arising, directly or indirectly, from any use of the information contained herein. Assets mentioned may be owned by members of the Market Briefing team. 

Reply

or to participate.